SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-22-000646
Filing Date
2022-05-03
Accepted
2022-05-03 17:29:28
Documents
110
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F g082980_20f.htm   iXBRL 20-F 2639540
2 EXHIBIT 2.1 g082980_ex2-1.htm EX-2.1 1506
3 EXHIBIT 2.4 g082980_ex2-4.htm EX-2.4 77232
4 EXHIBIT 4.15 g082980_ex4-15.htm EX-4.15 35002
5 EXHIBIT 4.17 g082980_ex4-17.htm EX-4.17 208875
6 EXHIBIT 4.18 g082980_ex4-18.htm EX-4.18 123103
7 EXHIBIT 4.19 g082980_ex4-19.htm EX-4.19 98975
8 EXHIBIT 4.20 g082980_ex4-20.htm EX-4.20 284957
9 EXHIBIT 4.21 g082980_ex4-21.htm EX-4.21 277650
10 EXHIBIT 4.22 g082980_ex4-22.htm EX-4.22 188822
11 EXHIBIT 4.23 g082980_ex4-23.htm EX-4.23 212272
12 EXHIBIT 4.24 g082980_ex4-24.htm EX-4.24 195522
13 EXHIBIT 4.25 g082980_ex4-25.htm EX-4.25 130856
14 EXHIBIT 4.26 g082980_ex4-26.htm EX-4.26 21239
15 EXHIBIT 4.27 g082980_ex4-27.htm EX-4.27 102821
16 EXHIBIT 11.1 g082980_ex11-1.htm EX-11.1 66232
17 EXHIBIT 12.1 g082980_ex12-1.htm EX-12.1 10866
18 EXHIBIT 12.2 g082980_ex12-2.htm EX-12.2 10937
19 EXHIBIT 13.1 g082980_ex13-1.htm EX-13.1 5410
20 EXHIBIT 13.2 g082980_ex13-2.htm EX-13.2 5565
21 EXHIBIT 15.1 g082980_ex15-1.htm EX-15.1 322232
22 EXHIBIT 15.2 g082980_ex15-2.htm EX-15.2 124989
23 EXHIBIT 15.3 g082980_ex15-3.htm EX-15.3 3589
24 GRAPHIC img001.jpg GRAPHIC 15439
25 GRAPHIC img001_v1.jpg GRAPHIC 24880
26 GRAPHIC img001_v4.jpg GRAPHIC 251900
27 GRAPHIC img002.jpg GRAPHIC 36094
28 GRAPHIC img002_v1.jpg GRAPHIC 11200
29 GRAPHIC img002_v3.jpg GRAPHIC 1024
30 GRAPHIC img002_v4.jpg GRAPHIC 56964
31 GRAPHIC img003.jpg GRAPHIC 6565
32 GRAPHIC img003_v3.jpg GRAPHIC 14599
33 GRAPHIC img004.jpg GRAPHIC 30883
34 GRAPHIC img005.jpg GRAPHIC 8642
35 GRAPHIC img006.jpg GRAPHIC 26909
  Complete submission text file 0001753926-22-000646.txt   10492511

Data Files

Seq Description Document Type Size
36 XBRL SCHEMA FILE xrtx-20211231.xsd EX-101.SCH 77959
37 XBRL CALCULATION FILE xrtx-20211231_cal.xml EX-101.CAL 54993
38 XBRL DEFINITION FILE xrtx-20211231_def.xml EX-101.DEF 166919
39 XBRL LABEL FILE xrtx-20211231_lab.xml EX-101.LAB 315665
40 XBRL PRESENTATION FILE xrtx-20211231_pre.xml EX-101.PRE 283919
104 EXTRACTED XBRL INSTANCE DOCUMENT g082980_20f_htm.xml XML 850266
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40858 | Film No.: 22888512
SIC: 2834 Pharmaceutical Preparations